Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Equity (2016 - 2025)

Iovance Biotherapeutics (IOVA) has disclosed Return on Equity for 9 consecutive years, with 0.56% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity fell 6.0% to 0.56% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.56%, a 6.0% decrease, with the full-year FY2025 number at 0.55%, up 2.0% from a year prior.
  • Return on Equity was 0.56% for Q4 2025 at Iovance Biotherapeutics, up from 0.57% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.48% in Q1 2023 to a low of 0.71% in Q1 2024.
  • A 3-year average of 0.57% and a median of 0.55% in 2025 define the central range for Return on Equity.
  • Biggest YoY gain for Return on Equity was 20bps in 2024; the steepest drop was -23bps in 2024.
  • Iovance Biotherapeutics' Return on Equity stood at 0.71% in 2023, then rose by 29bps to 0.5% in 2024, then fell by -11bps to 0.56% in 2025.
  • Per Business Quant, the three most recent readings for IOVA's Return on Equity are 0.56% (Q4 2025), 0.57% (Q3 2025), and 0.53% (Q2 2025).